Electrocorticographic Monitoring of Brain Retraction Injury (EMBRI)
EMBRI
Electrocorticography As a Neurophysiological Marker for Intraoperative Monitoring for Brain Retraction: an IDEAL Stage 1 Study
1 other identifier
interventional
6
1 country
1
Brief Summary
A single centre IDEAL Stage 1 feasibility study using novel electrophysiological recording techniques in adult participants undergoing neurosurgery. This is a first in human study, building upon previous preclinical mice experiments. Participants will undergo their planned neurosurgical procedure as normal. In addition to their standard treatment neurophysiological monitoring including an electrocorticography electrode placed on the brain deep to the retractor will be used to monitor for signs of brain retraction injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2022
CompletedFirst Submitted
Initial submission to the registry
May 1, 2024
CompletedFirst Posted
Study publicly available on registry
May 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedSeptember 19, 2024
September 1, 2024
2.3 years
May 1, 2024
September 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluate the feasibility of integrating the ECoG brain retractor into standard traditional neurosurgical operative workflow.
The primary outcome is to report the feasibility of integrating the ECoG brain retractor into standard traditional neurosurgical operative workflow based upon analysing prospective data including qualitative questionnaires administered to surgeons and scrub nurses, anonymised clinical data, and anonymised electrophysiological data. The primary outcome is to produce a descriptive report of the electrophysiological data recorded and the challenges encountered in the delivery of the novel electrophysiological recording for patients undergoing planned neurosurgical procedures at the National Hospital for Neurology and Neurosurgery, London.
Over a 28 month period from November 2022 to March 2026
Secondary Outcomes (1)
Analyse the captured electrophysiological data to investigate any correlation between the electrophysiological signature and duration of retraction.
Over a 28 month period from November 2022 to March 2026
Study Arms (1)
Intervention arm
EXPERIMENTALInterventions
The patient will undergo their intracranial neurosurgical procedure as planned, using conventional brain retractors and neurosurgical equipment. Standard neuromonitoring (EEG, MEP, SSEP) will be placed after the induction of neuroanaesthesia if indicated. Additional to whatever conventional EMBRI neuromonitoring is used, intraoperatively an ECoG array will be positioned under the retractor by the operating surgeon. Further electrode arrays may be placed on the cortical surface remote from the retractor as needed to establish a reference. Typically we anticipate one ECoG array under the retractor blade with a reference array on an area of unretracted brain.
Eligibility Criteria
You may qualify if:
- Patients aged 16 or older undergoing intracranial surgery where it is anticipated fixed brain retraction will be used.
You may not qualify if:
- Patients without capacity to give consent at time of recruitment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Hospital Neurology and Neurosurgery
London, Greater London, WC1N 3BG, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 1, 2024
First Posted
May 10, 2024
Study Start
August 1, 2022
Primary Completion
December 1, 2024
Study Completion
March 1, 2026
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share